Design, computational studies, synthesis and biological evaluation of thiazole-based molecules as anticancer agents

European Journal of Pharmaceutical Sciences - Tập 134 - Trang 20-30 - 2019
Anuradha1, Sagarkumar Patel1, Rajkumar Patle1, Preethi Parameswaran1, Alok Jain2, Amit Shard1
1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Ahmedabad, Opposite Air Force Station, Gandhinagar, Gujarat, 382355, India
2Department of Biotechnology, National Institute of Pharmaceutical Education and Research Ahmedabad, Opposite Air Force Station, Gandhinagar, Gujarat 382355, India

Tài liệu tham khảo

Abraham, 2015, GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers, 19 Akl, 2014, A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum, Biochim. Biophys. Acta (BBA) – Mol. Cell Res., 1843, 2240, 10.1016/j.bbamcr.2014.04.017 Ali, 2015, Heterocyclic scaffolds: centrality in anticancer drug development, Curr. Drug Targets, 16, 711, 10.2174/1389450116666150309115922 Ayalew, 2017, Conjugation of paclitaxel to hybrid peptide carrier and biological evaluation in Jurkat and A549 cancer cell lines, ACS Med. Chem. Lett., 8, 814, 10.1021/acsmedchemlett.7b00117 Ayati, 2015, Recent applications of 1, 3-thiazole core structure in the identification of new lead compounds and drug discovery, Eur. J. Med. Chem., 97, 699, 10.1016/j.ejmech.2015.04.015 Azmi, 2011, Emerging Bcl-2 inhibitors for the treatment of cancer, Expert Opin. Emerg. Drugs, 16, 59, 10.1517/14728214.2010.515210 Baell, 2010, New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays, J. Med. Chem., 53, 2719, 10.1021/jm901137j Bartocci, 2016, Computational modeling, formal analysis, and tools for systems biology, PLoS Comput. Biol., 12, 10.1371/journal.pcbi.1004591 Berendsen, 1981, Interaction models for water in relation to protein hydration, 331 Berman, 2000, The protein data bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 Biswas, 2018, Drug development and bioanalytical method validation for a novel anticancer molecule, 4‐(dimethylamino)‐2‐(p‐tolylamino) thiazole‐5‐carbonitrile, Drug Dev. Res., 79, 391, 10.1002/ddr.21462 Bodur, 2012, Bcl-2 inhibitors: emerging drugs in cancer therapy, Curr. Med. Chem., 19, 1804, 10.2174/092986712800099839 Bussi, 2007, Canonical sampling through velocity rescaling, J. Chem. Phys., 126, 10.1063/1.2408420 Chen, 2000, Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis, Cell Death Differ., 7, 227, 10.1038/sj.cdd.4400629 Darzynkiewicz, 1997, Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis), Cytometry, 27, 1, 10.1002/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L Duran-Frigola, 2013, Structural systems pharmacology: the role of 3D structures in next-generation drug development, Chem. Biol., 20, 674, 10.1016/j.chembiol.2013.03.004 Essmann, 1995, A smooth particle mesh Ewald method, J. Chem. Phys., 103, 8577, 10.1063/1.470117 Ferrao, 2015, Cellular and phenotypic plasticity in cancer, Front. Oncol., 5, 171, 10.3389/fonc.2015.00171 Ferreira, 2015, Molecular docking and structure-based drug design strategies, Molecules, 20, 13384, 10.3390/molecules200713384 Fleming, 2010, Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore, J. Med. Chem., 53, 7902, 10.1021/jm100762r Frenzel, 2009, Bcl2 family proteins in carcinogenesis and the treatment of cancer, Apoptosis, 14, 584, 10.1007/s10495-008-0300-z Garattini, 1997, Are me-too drugs justified, J. Nephrol., 10, 283 Goodsell, 2015, The RCSB PDB “molecule of the month”: inspiring a molecular view of biology, PLoS Biol., 13, 10.1371/journal.pbio.1002140 Harder, 2015, OPLS3: a force field providing broad coverage of drug-like small molecules and proteins, J. Chem. Theory Comput., 12, 281, 10.1021/acs.jctc.5b00864 Hess, 1997, LINCS: a linear constraint solver for molecular simulations, J. Comput. Chem., 18, 1463, 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H Hodgkins, 1956, The synthesis of isothiocyanates from amines, J. Org. Chem., 21, 404, 10.1021/jo01110a006 Homeyer, 2012, Free energy calculations by the molecular mechanics Poisson− Boltzmann surface area method, Mol. Inf., 31, 114, 10.1002/minf.201100135 Huber, 2014, Heteroaromatic π-stacking energy landscapes, J. Chem. Inf. Model., 54, 1371, 10.1021/ci500183u Huigsloot, 2002, Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells, J. Biol. Chem., 277, 35869, 10.1074/jbc.M200378200 Kumari, 2014, g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations, J. Chem. Inf. Model., 54, 1951, 10.1021/ci500020m Lama, 2008, Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, bad, and Bim proteins: comparative molecular dynamics simulations, Proteins: Struct., Funct., Bioinf., 73, 492, 10.1002/prot.22075 Leoni, 2014, Novel thiazole derivatives: a patent review (2008–2012; part 1), Expert Opin. Ther. Pat., 24, 201, 10.1517/13543776.2014.858121 Leung, 1999, Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7, Breast Cancer Res. Treat., 55, 73, 10.1023/A:1006190802590 Liu, 2014, Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration resistant prostate cancer, Clin. Cancer Res., 3296 Lu, 2011, Design, synthesis, and SAR studies of 4-substituted methoxylbenzoyl-aryl-thiazoles analogues as potent and orally bioavailable anticancer agents, J. Med. Chem., 54, 4678, 10.1021/jm2003427 Lu, 2017, Anticancer drug development, getting out from bottleneck, Med. Chem., 7, 739, 10.4172/2161-0444.1000423 Malde, 2011, An automated force field topology builder (ATB) and repository: version 1.0, J. Chem. Theory Comput., 7, 4026, 10.1021/ct200196m Nogrady, 2005 Ntie-Kang, 2013, An in silico evaluation of the ADMET profile of the StreptomeDB database, Springer Plus, 2, 353, 10.1186/2193-1801-2-353 Oancea, 2006, Apoptosis assays, 279 Palchaudhuri, 2015, A small molecule that induces intrinsic pathway apoptosis with unparalleled speed, Cell Rep., 13, 2027, 10.1016/j.celrep.2015.10.042 Pang, 2012, Bak conformational changes induced by ligand binding: insight into BH3 domain binding and Bak homo-oligomerization, Sci. Rep., 2, 257, 10.1038/srep00257 Parrinello, 1981, Polymorphic transitions in single crystals: a new molecular dynamics method, J. Appl. Phys., 52, 7182, 10.1063/1.328693 Perini, 2018, BCL-2 as therapeutic target for hematological malignancies, J. Hematol. Oncol., 11, 65, 10.1186/s13045-018-0608-2 Petros, 2004, Structural biology of the Bcl-2 family of proteins, Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1644, 83, 10.1016/j.bbamcr.2003.08.012 Pettersen, 2004, UCSF chimera—a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 Rajappa, 1982, A general synthesis of thiazoles. Part 4. Synthesis of 5-acyl-2, 4-diaminothiazoles, J. Chem. Sci., 91, 441, 10.1007/BF02864180 Rastelli, 2010, Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA, J. Comput. Chem., 31, 797 Romagnoli, 2012, Synthesis and biological evaluation of 2-substituted-4-(3′, 4′, 5′-trimethoxyphenyl)-5-aryl thiazoles as anticancer agents, Bioorg. Med. Chem., 20, 7083, 10.1016/j.bmc.2012.10.001 Schmid, 2011, Definition and testing of the GROMOS force-field versions 54A7 and 54B7, Eur. Biophys. J., 40, 843, 10.1007/s00249-011-0700-9 Schwede, 2003, SWISS-MODEL: an automated protein homology-modeling server, Nucleic Acids Res., 31, 3381, 10.1093/nar/gkg520 Sharifi, 2015, Doxorubicin changes Bax/Bcl-xL ratio, caspase-8 and 9 in breast cancer cells, Adv. Pharm. Bull., 5, 351, 10.15171/apb.2015.049 Singh, 2016, Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines, BMC Cancer, 16, 77, 10.1186/s12885-016-2082-y Sleebs, 2013, Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL, J. Med. Chem., 56, 5514, 10.1021/jm400556w Souers, 2013, ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets, Nat. Med., 19, 202, 10.1038/nm.3048 Stroet, 2018, The automated topology builder version 3.0 (ATB3. 0): prediction of solvation free enthalpies in water and hexane, J. Chem. Theory Comput., 14, 5834, 10.1021/acs.jctc.8b00768 T Chhabria, 2016, Thiazole: a review on chemistry, synthesis and therapeutic importance of its derivatives, Curr. Top. Med. Chem., 16, 2841, 10.2174/1568026616666160506130731 Touré, 2013, The role of the acidity of N-heteroaryl sulfonamides as inhibitors of Bcl-2 family protein–protein interactions, ACS Med. Chem. Lett., 4, 186, 10.1021/ml300321d Toure, 2013, The role of the acidity of N-heteroaryl sulfonamides as inhibitors of bcl-2 family protein interactions, ACS Med. Chem. Lett., 4, 186, 10.1021/ml300321d Wang, 2017, Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease Weis, 2006, Ligand affinities predicted with the MM/PBSA method: dependence on the simulation method and the force field, J. Med. Chem., 49, 6596, 10.1021/jm0608210 Xu, 2016, Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen, Nat. Med., 22, 1101, 10.1038/nm.4184